India · Delayed Price · Currency is INR Dr. Agarwal's Health Care Statistics
Total Valuation
BOM:544350 has a market cap or net worth of INR 158.55 billion. The enterprise value is 167.32 billion.
| Market Cap | 158.55B |
| Enterprise Value | 167.32B |
Important Dates
The last earnings date was Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 316.98M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.13% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 22.48% |
| Owned by Institutions (%) | 11.87% |
| Float | 121.03M |
Valuation Ratios
The trailing PE ratio is 106.86 and the forward PE ratio is 75.56.
| PE Ratio | 106.86 |
| Forward PE | 75.56 |
| PS Ratio | 7.19 |
| PB Ratio | 7.48 |
| P/TBV Ratio | 18.17 |
| P/FCF Ratio | 223.19 |
| P/OCF Ratio | 30.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 27.82, with an EV/FCF ratio of 235.53.
| EV / Earnings | 112.77 |
| EV / Sales | 7.58 |
| EV / EBITDA | 27.82 |
| EV / EBIT | 52.22 |
| EV / FCF | 235.53 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 1.77 |
| Debt / FCF | 15.01 |
| Interest Coverage | 3.60 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.56% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:544350 has paid 850.80 million in taxes.
| Income Tax | 850.80M |
| Effective Tax Rate | 31.49% |
Stock Price Statistics
The stock price has increased by +10.97% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +10.97% |
| 50-Day Moving Average | 487.39 |
| 200-Day Moving Average | 473.14 |
| Relative Strength Index (RSI) | 49.15 |
| Average Volume (20 Days) | 84,624 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544350 had revenue of INR 22.07 billion and earned 1.48 billion in profits. Earnings per share was 4.65.
| Revenue | 22.07B |
| Gross Profit | 9.62B |
| Operating Income | 3.20B |
| Pretax Income | 2.70B |
| Net Income | 1.48B |
| EBITDA | 5.02B |
| EBIT | 3.20B |
| Earnings Per Share (EPS) | 4.65 |
Balance Sheet
The company has 2.84 billion in cash and 10.66 billion in debt, with a net cash position of -7.82 billion.
| Cash & Cash Equivalents | 2.84B |
| Total Debt | 10.66B |
| Net Cash | -7.82B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 21.20B |
| Book Value Per Share | 63.93 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was 5.19 billion and capital expenditures -4.48 billion, giving a free cash flow of 710.40 million.
| Operating Cash Flow | 5.19B |
| Capital Expenditures | -4.48B |
| Depreciation & Amortization | 1.82B |
| Net Borrowing | -2.23B |
| Free Cash Flow | 710.40M |
| FCF Per Share | n/a |
Margins
Gross margin is 43.61%, with operating and profit margins of 14.52% and 6.72%.
| Gross Margin | 43.61% |
| Operating Margin | 14.52% |
| Pretax Margin | 12.24% |
| Profit Margin | 6.72% |
| EBITDA Margin | 22.76% |
| EBIT Margin | 14.52% |
| FCF Margin | 3.42% |
Dividends & Yields
BOM:544350 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.13% |
| Shareholder Yield | -3.13% |
| Earnings Yield | 0.94% |
| FCF Yield | 0.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:544350 is 584.20, which is 16.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 584.20 |
| Price Target Difference | 16.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 20.77% |
| EPS Growth Forecast (3Y) | 40.82% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |